Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by De Vos, A.
Right arrow Articles by Van Steirteghem, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Vos, A.
Right arrow Articles by Van Steirteghem, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 7, 1859-1863, July 1999
© 1999 European Society of Human Reproduction and Embryology

In-vitro matured metaphase-I oocytes have a lower fertilization rate but similar embryo quality as mature metaphase-II oocytes after intracytoplasmic sperm injection

A. De Vos1, H. Van de Velde, H. Joris and A. Van Steirteghem

Centre for Reproductive Medicine, University Hospital, Dutch-speaking Brussels Free University (Vrije Universiteit Brussel), Laarbeeklaan 101, B-1090 Brussels, Belgium

About 4% of all the oocytes denuded prior to intracytoplasmic sperm injection (ICSI) are in metaphase-I (MI). Frequently, these oocytes achieve meiosis after a few hours of in-vitro culture and are available for ICSI on the day of oocyte retrieval. In this retrospective study, the aim was to evaluate the fertilization rate and the developmental capacity of these in-vitro matured MI oocytes. After controlled ovarian stimulation using human menopausal gonadotrophin (HMG) and human chorionic gonadotrophin (HCG) in 896 ICSI cycles, 1210 MI-to-MII-matured oocytes were injected ~4 h after in-vitro culture and 8803 MII oocytes were injected immediately, or later, after denudation. The fertilization rate of in-vitro matured oocytes was significantly lower than that of mature MII oocytes (52.7 and 70.8% respectively, P < 0.00l). Embryo quality was only slightly different as regards the numbers of good quality embryos: 47.4% good quality embryos were obtained in the in-vitro matured oocyte group, whereas 53.2% good quality embryos were obtained in the MII oocyte group (P < 0.05). The same proportions of excellent (5.7 and 7.0%, NS) and fair quality (17.6 and 15.3%, NS) embryos were obtained for in-vitro matured and mature oocytes respectively. Embryos derived from in-vitro matured oocytes were transferred only if they were of better quality or if there were not enough mature oocyte derived embryos available. Fifteen transfers involved only embryos derived from in-vitro matured oocytes: 11 single embryo transfers and four transfers of two embryos, resulting in one singleton pregnancy and the birth of a healthy baby. It may be concluded that in cycles with few MII oocytes it might be worthwhile to inject in-vitro matured MI oocytes in order to increase the number of embryos available for transfer.

Key words: embryo cleavage/fertilization/intracytoplasmic sperm injection/metaphase-I oocyte/oocyte in-vitro maturation

1 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
C. Dupont, B. D. Bavister, D. R. Armant, and C. A. Brenner
Rhesus macaque embryos derived from MI oocytes maturing after retrieval display high rates of chromosomal anomalies
Hum. Reprod., April 1, 2009; 24(4): 929 - 935.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. M. Jones, D. S. Cram, B. Song, M. C. Magli, L. Gianaroli, O. Lacham-Kaplan, J. K. Findlay, G. Jenkin, and A. O. Trounson
Gene expression profiling of human oocytes following in vivo or in vitro maturation
Hum. Reprod., May 1, 2008; 23(5): 1138 - 1144.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E.M. Kolibianakis, K. Zikopoulos, W. Verpoest, M. Camus, H. Joris, A.C. Van Steirteghem, and P. Devroey
Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer?
Hum. Reprod., November 1, 2004; 19(11): 2550 - 2554.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Kolibianakis, K. Zikopoulos, M. Camus, H. Tournaye, A. Van Steirteghem, and P. Devroey
Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation
Hum. Reprod., November 1, 2004; 19(11): 2545 - 2549.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Strassburger, S. Friedler, A. Raziel, E. Kasterstein, M. Schachter, and R. Ron-El
The outcome of ICSI of immature MI oocytes and rescued in vitro matured MII oocytes
Hum. Reprod., July 1, 2004; 19(7): 1587 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Balakier, A. Sojecki, G. Motamedi, and C. Librach
Time-dependent capability of human oocytes for activation and pronuclear formation during metaphase II arrest
Hum. Reprod., April 1, 2004; 19(4): 982 - 987.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Tsuchiya, Y. Kamiguchi, K. Sengoku, and M. Ishikawa
A cytogenetic study of in-vitro matured murine oocytes after ICSI by human sperm
Hum. Reprod., February 1, 2002; 17(2): 420 - 425.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.L. Cavilla, C.R. Kennedy, M. Baltsen, L.D. Klentzeris, A.G. Byskov, and G.M. Hartshorne
The effects of meiosis activating sterol on in-vitro maturation and fertilization of human oocytes from stimulated and unstimulated ovaries
Hum. Reprod., March 1, 2001; 16(3): 547 - 555.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.